Phenylpropanolamine in drugs could be a risk for strokeBMJ 2000; 321 doi: https://doi.org/10.1136/bmj.321.7268.1037/a (Published 28 October 2000) Cite this as: BMJ 2000;321:1037
- Fred Charatan
A five year study by Yale University, Connecticut, has found a small, but significant risk of haemorrhagic stroke in women taking non-prescription cough and cold medicines, appetite suppressants, and some prescription decongestants containing phenylpropanolamine (PPA).
After hearing the evidence presented by the researchers—who were headed by Dr Walter Kernan, an associate professor of medicine at Yale—an advisory 14 member panel of the US Food and Drug Administration (FDA) voted overwhelmingly to ban …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial